Clinical Trial Update: Medicine-induced Cardiac Hemodialysis on COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 trial update on a medicine-related cardiac hemodialysis approach for COVID-19; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection Viral
• Myocarditis Allergic
• Renal Dialysis
• Respiratory Syndrome-related Coronavirus

Snippet

Sponsor: Yang I. Pachankis | Conditions: Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis | Phase 4 | Status: COMPLETED